Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-1.05	36.64	37.03
Graham Fair Price	-15.38	7.25	8.57
PEG	440.59	-0.50	0.09
Price/Book	-7.04	8.93	9.60
Price/Cash Flow	243.21	68.47	19.95
Prices/Earnings	53.05	16.28	10.64
Price/Sales	4.86	4.02	3.83
Price/FCF	243.21	68.47	19.95
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	3.42	0.29	0.28
Operating Margin	1.73	0.16	0.15
ROA	-33.86	0.01	0.02
ROE	0.23	0.14	-39.26
ROIC	0.04	0.03	-36.41
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.04	79.80
Dividends QOQ	< 0.005	0.05	1310.92
EBIT QOQ	0.33	-0.02	-94.54
EPS QOQ	1.15	-0.33	-71.69
FCF QOQ	0.92	-0.71	-23.31
Revenue QOQ	< 0.005	-0.03	-1017.43
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	70.35	75.38	7.16
Days Sales Outstanding (DSO)	38.03	44.07	15.87
Inventory Turnover	1.28	1.19	-6.68
Debt/Capitalization	0.90	0.89	-0.99
Quick Ratio	0.62	0.67	8.59
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.80	4.13	8.58
Cash	2.40	2.43	1.65
Capex	-0.41	-0.33	20.66
Free Cash Flow	1.83	0.54	-70.59
Revenue	9.53	9.18	-3.74
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.30	1.33	1.92
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	16.92	16.55	-2.20
Naive Interpretation	Member

06 - Financial Health · Weak

Rating